COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review and meta-analysis
JW Senefeld, M Franchini, C Mengoli… - JAMA network …, 2023 - jamanetwork.com
Importance Patients who are immunocompromised have increased risk for morbidity and
mortality associated with coronavirus disease 2019 (COVID-19) because they less …
mortality associated with coronavirus disease 2019 (COVID-19) because they less …
[HTML][HTML] Vaccines and therapeutics for immunocompromised patients with COVID-19
The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …
This diverse group is at increased risk for impaired vaccine responses, progression to …
Clinical practice guidelines from the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 convalescent plasma
Description: Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a
potential treatment of COVID-19. However, meta-analysis data and recommendations are …
potential treatment of COVID-19. However, meta-analysis data and recommendations are …
[HTML][HTML] Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
In the post-pandemic COVID-19 period, human activities have returned to normal and
COVID-19 cases are usually mild. However, patients with multiple myeloma (MM) present an …
COVID-19 cases are usually mild. However, patients with multiple myeloma (MM) present an …
Guidance on the use of convalescent plasma to treat immunocompromised patients with coronavirus disease 2019
Abstract Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) is a safe and
effective treatment for COVID-19 in immunocompromised (IC) patients. IC patients have a …
effective treatment for COVID-19 in immunocompromised (IC) patients. IC patients have a …
Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ. 1.1 and XBB. 1
DJ Sullivan, M Franchini… - Journal of General …, 2023 - microbiologyresearch.org
Recent 2022 SARS-CoV-2 Omicron variants, have acquired resistance to most neutralizing
anti-Spike monoclonal antibodies authorized, and the BQ. 1.* sublineages are notably …
anti-Spike monoclonal antibodies authorized, and the BQ. 1.* sublineages are notably …
Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
JG Ripoll, EK Gorman, JE Juskewitch… - Blood …, 2022 - ashpublications.org
Although severe coronavirus disease 2019 (COVID-19) and death from COVID-19 are
generally preventable in immunocompetent people in areas of the world with sufficient …
generally preventable in immunocompetent people in areas of the world with sufficient …
[PDF][PDF] Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization
Understanding the mechanisms of antibody-mediated neutralization of SARS-CoV-2 is
critical in combating the COVID-19 pandemic. Based on previous reports of antibody …
critical in combating the COVID-19 pandemic. Based on previous reports of antibody …
[PDF][PDF] Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells
AK Singh, R Wang, KA Lombardo, M Praharaj… - Iscience, 2023 - cell.com
Summary Bacillus Calmette-Guérin (BCG) confers heterologous immune protection against
viral infections and has been proposed as vaccine against SARS-CoV-2 (SCV2). Here, we …
viral infections and has been proposed as vaccine against SARS-CoV-2 (SCV2). Here, we …
[HTML][HTML] Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases
A Otiniano, Z van de Wyngaert, E Brissot… - Bone Marrow …, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is life-threatening
for patients with haematologic malignancies [1]. The Omicron variant that emerged at the …
for patients with haematologic malignancies [1]. The Omicron variant that emerged at the …